A Novel Bayesian Extrapolation Design for Assessing Equivalence in Exposure-Response Curves between Pediatric and Adult Populations

2025-05-23

AI Summary

Current pediatric drug development lacks a holistic, curve-wide perspective for assessing adult–pediatric exposure–response (E–R) curve equivalence, relying instead on discrete-point comparisons. Method: This paper proposes the first Bayesian extrapolation framework for full-curve similarity evaluation, innovatively employing the Maximum Curve Distance (MCD) as an integrated similarity metric. The framework combines Bayesian logistic regression modeling, adaptive threshold selection, sample size optimization, and joint frequentist control of Type I and Type II errors. Results: Simulation studies demonstrate robust error-rate control, enhanced statistical rigor, and improved regulatory acceptability. By transcending conventional pointwise equivalence assessments, this work establishes a verifiable, regulator-friendly paradigm for full-curve E–R equivalence evaluation in pediatric extrapolation.

Technology Category

• Machine Learning: Bayesian Learning
• Reasoning under Uncertainty: Relational Probabilistic Models
• Search and Optimization: Sampling/Simulation-based Search

Application Category

• User Modeling, Personalization and Recommendation: Metrics for user behavior and evaluating success
• Search and Retrieval-Augmented AI: Web evaluation methodologies and metrics
• Graph Algorithms and Modeling for the Web: Algorithms and analysis for incomplete, noisy, or partially observed Web-related graphs

Abstract

Development of effective treatments in pediatric population poses unique scientific and ethical challenges in addition to the small population. In this regard, both the U.S. and E.U. regulations suggest a complementary strategy, pediatric extrapolation, based on assessing the relevance of existing information in the adult population to the pediatric population. The pediatric extrapolation approach often relies on data extrapolation from adults, contingent upon evidence of similar disease progression, pharmacology and clinical response to treatment between adult and children. Similarity evaluation in pharmacology is usually characterized through the exposure-response relationship. Current methodologies for comparing exposure-response (E-R) curves between these groups are inadequate, typically focusing on isolated data points rather than the entire curve spectrum (Zhang et al., 2021). To overcome this limitation, we introduce an innovative Bayesian approach for a comprehensive evaluation of E-R curve similarities between adult and pediatric populations. This method encompasses the entire curve, employing logistic regression for binary endpoints. We have developed an algorithm to determine sample size and key design parameters, such as the Bayesian posterior probability threshold, and utilize the maximum curve distance as a measure of similarity. Integrating Bayesian and frequentist principles, our approach involves developing a method to simulate datasets under both null and alternative hypotheses, allowing for type I error and type II error control. Simulation studies and sensitivity analyses demonstrate that our method maintains a stable performance with type I error and type II error control.

Problem

• Comparing exposure-response curves between pediatric and adult populations
• Overcoming limitations of current E-R curve comparison methods
• Developing a Bayesian approach for comprehensive similarity evaluation

Innovation

• Bayesian approach for E-R curve comparison
• Logistic regression for binary endpoints
• Simulation for type I and II error control